Entia Biosciences Inc (ERGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,046 | -535 | -3,105 | -2,001 | -1,491 |
| Depreciation Amortization | 274 | 77 | 432 | 103 | 66 |
| Accounts receivable | -20 | -25 | -31 | -31 | -19 |
| Other Working Capital | 216 | 193 | 613 | 533 | 385 |
| Other Operating Activity | 318 | 199 | 1,324 | 906 | 744 |
| Operating Cash Flow | $-257 | $-92 | $-767 | $-490 | $-314 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3 | N/A | -53 | -55 | -38 |
| Purchase Sale Intangibles | -7 | -4 | -12 | -20 | -5 |
| Other Investing Activity | -7 | -4 | -12 | -20 | -5 |
| Investing Cash Flow | $-10 | $-4 | $-65 | $-76 | $-43 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 267 | 92 | 191 | 50 | N/A |
| Common Stock Issued | N/A | N/A | 701 | 566 | 372 |
| Other Financing Activity | -21 | -10 | -37 | -18 | -14 |
| Financing Cash Flow | $246 | $82 | $855 | $598 | $358 |
| Beginning Cash Position | 37 | 37 | 13 | 13 | 13 |
| End Cash Position | 16 | 23 | 37 | 45 | 13 |
| Net Cash Flow | $-21 | $-14 | $24 | $32 | $0 |
| Free Cash Flow | |||||
| Operating Cash Flow | -257 | -92 | -767 | -490 | -314 |
| Capital Expenditure | -3 | N/A | -53 | -55 | -38 |
| Free Cash Flow | -260 | -92 | -819 | -545 | -353 |